Share Email Print

Proceedings Paper • new

Low level laser therapy (photobiomodulation) for the management of breast cancer-related lymphedema: an update
Author(s): G. David Baxter; Lizhou Liu; Cathy Chapple; Simone Petrich; Juanita J. Anders; Steve Tumilty
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Breast cancer related lymphedema (BCRL) is prevalent among breast cancer survivors, and may be painful and disfiguring with associated psychological impact. Previous research shows increasing use of low level laser therapy (LLLT), now commonly referred to as photobiomodulation (PBM) therapy for managing BCRL, in countries including the United States and Australia. However, conclusions were limited by the paucity, heterogeneity, and poor quality of previous studies. LLLT (PBM) has been barely used in clinical practice in New Zealand, and no clinical studies on LLLT (PBM) for BCRL have been conducted in this country. In order to promote this potentially useful treatment modality for BCRL patients, the Laser Lymphedema Trial Team at the University of Otago conducted a program to assess the effectiveness of LLLT (PBM) in management of BCRL. The program comprises three phases including a systematic review (completed), a feasibility study (completed), and a full-scale randomized controlled trial (proposed). This current paper provides an update on the program. Based upon the systematic review, LLLT (PBM) is considered a potentially effective treatment approach for women with BCRL; the review also indicated the need for further research including exploration of the relevance of dosage and other LLLT (PBM) parameters. The feasibility study demonstrated that it is feasible to conduct a fully powered RCT to definitively test the effectiveness of the additional use of LLLT (PBM) in the management of BCRL, and 114 participants will be needed at baseline in the main study. Currently, the full-scale RCT is under preparation.

Paper Details

Date Published: 12 April 2018
PDF: 6 pages
Proc. SPIE 10582, Laser Florence 2017: Advances in Laser Medicine, 1058202 (12 April 2018); doi: 10.1117/12.2315544
Show Author Affiliations
G. David Baxter, Univ. of Otago (New Zealand)
Lizhou Liu, Univ. of Otago (New Zealand)
Cathy Chapple, Univ. of Otago (New Zealand)
Simone Petrich, Southern District Health Board (New Zealand)
Juanita J. Anders, Uniformed Services Univ. of the Health Sciences (United States)
Steve Tumilty, Univ. of Otago (New Zealand)

Published in SPIE Proceedings Vol. 10582:
Laser Florence 2017: Advances in Laser Medicine
Leonardo Longo, Editor(s)

© SPIE. Terms of Use
Back to Top